Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Acuitas Therapeutics Inc. v. Genevant Sciences GmbH et al
Case Number:
1:22-cv-02229
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 05, 2022
Developers Tied To Pfizer COVID Vaccine Want IP Suit Tossed
Two developers of the mRNA delivery system used in Pfizer and BioNTech's COVID-19 vaccine have urged a New York federal judge to toss a suit from Acuitas Therapeutics Inc. seeking a declaration that the sale of Pfizer's COVID-19 Comirnaty vaccine does not infringe nine of the developers' patents.
-
March 18, 2022
Pfizer Vaccine Delivery Designer Wants Rival's Patents Axed
A pharmaceutical company that says it developed the mRNA delivery system it licenses to Pfizer and BioNTech for use in their COVID-19 vaccine asked a New York federal judge to strike down nine patents owned by two rival mRNA developers and declare they aren't infringed by Pfizer's Comirnaty vaccine.